Fibrosis clinical trials
The registry lists 3,256 studies for Fibrosis across more than 10 countries. 466 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 1,829
- Status unknown
- 496
- Recruiting
- 326
- Terminated
- 256
- Withdrawn
- 115
- Not yet recruiting
- 114
Phase
- Phase 2
- 616
- Phase 3
- 381
- Phase 1
- 310
- Phase 4
- 229
- Early Phase 1
- 24
Where
- United States
- 1,055
- France
- 395
- United Kingdom
- 345
- China
- 300
- Germany
- 259
- Canada
- 259
Who runs them
Vertex Pharmaceuticals Incorporated (79) · Institute of Liver and Biliary Sciences, India (71) · Assistance Publique - Hôpitaux de Paris (48) · Hospices Civils de Lyon (41) · Boehringer Ingelheim (39) · Gilead Sciences (38) · Novartis Pharmaceuticals (27) · University of Pittsburgh (24)
Studies
Recruiting first, then most recently updated. Showing 50 of 3,256 — search for more.
- Novel Tracer Methods to Evaluate Muscle Protein Metabolism in CirrhosisRecruitingNCT032256771 country
- Vericiguat and Reverse Remodeling Indices in Heart FailureRecruitingNCT07405944Phase 41 country
- Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)Not yet recruitingNCT07820995Phase 41 country
- Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's DiseaseRecruitingNCT071524311 country
- VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)RecruitingNCT073903441 country
- A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)RecruitingNCT07701993Phase 32 countries
- A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)RecruitingNCT07704892Phase 32 countries
- Chronic Pain Optimization and Management for Relief and Functionality With TEA in CirrhosisNot yet recruitingNCT07820917Not applicable1 country
- Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic SteatohepatitisRecruitingNCT035724651 country
- Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch ViscoelastographyRecruitingNCT063168691 country
- Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9Not yet recruitingNCT07652203Not applicable1 country
- A Prospective Study of Memantine in Patients With Cirrhosis and Liver CancerRecruitingNCT06007846Phase 2/31 country
- Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver DiseaseRecruitingNCT036355411 country
- Hepatic Impairment With Cirrhosis Due to Cholestatic Liver DiseaseRecruitingNCT05045482Phase 11 country
- Empagliflozin in Patients With Cirrhosis and AscitesRecruitingNCT05726032Phase 21 country
- Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary FibrosisRecruitingNCT07679893Phase 21 country
- Oral or Topical Catechins for Radiation DermatitisEnrolling by invitationNCT07149506Phase 31 country
- Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)RecruitingNCT06494111Phase 21 country
- EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPGRecruitingNCT06863012Not applicable1 country
- Study of Resmetirom in Children and Adolescents With MASHRecruitingNCT07763015Phase 21 country
- A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)RecruitingNCT07816185Phase 31 country
- Using Bedside Ultrasound to Understand Fluid Management in Patients With Chronic Liver DiseaseNot yet recruitingNCT07810855
- Prospective Stage-Stratified Histopathologic Study and Proposed Disease-Evolution Model of Gluteal Permanent Synthetic Filler ComplicationsNot yet recruitingNCT078089701 country
- Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]RecruitingNCT06125743Not applicable1 country
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHRecruitingNCT06419374Phase 325 countries
- A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)RecruitingNCT06318169Phase 327 countries
- Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)RecruitingNCT05531786Phase 1/21 country
- A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILDRecruitingNCT07333183Phase 21 country
- Role of Allopurinol in Prevention of Complications Related to Decompensated Cirrhosis of LiverRecruitingNCT07800598Phase 41 country
- Predictors of Mortality in Cirrhotic Patients With Acute Kidney InjuryNot yet recruitingNCT07797114
- Body-weight Reduction Effect on Portal Hypertension in Compensated CirrhosisNot yet recruitingNCT07797101Not applicable
- Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical OutcomesNot yet recruitingNCT077954761 country
- The Application of Lifestyle Enhancing Validated Integrative Therapies for Everyday Pain in CirrhosisNot yet recruitingNCT07792850Not applicable1 country
- Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and AgeingRecruitingNCT062105551 country
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT003738411 country
- Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASHRecruitingNCT07335601Phase 22 countries
- hepatomiR cACLD StudyRecruitingNCT064325821 country
- Application of Different Scores in Predicting Outcomes of Cirrhotic Patients Awaiting Liver TransplantationNot yet recruitingNCT07777705
- Detecting Liver Fibrosis in Patients At-riskNot yet recruitingNCT077756381 country
- Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney InjuryRecruitingNCT06937307Phase 21 country
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT054637961 country
- Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)Not yet recruitingNCT07216859Not applicable1 country
- Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart DiseaseRecruitingNCT010999821 country
- Predicting Response and Exposure Changes in Cirrhosis for EffectivenessNot yet recruitingNCT07750587Not applicable
- Dose-Escalation Study of Artesunate Patients With IPFRecruitingNCT05988463Phase 11 country
- WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT06967805Phase 212 countries
- Development and Testing of a Patient-facing Educational Tool About Liver Cancer PreventionRecruitingNCT070103151 country
- Adverse Outcomes and Mortality in Liver TransplantRecruitingNCT05477277Not applicable1 country
- Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) PlacementRecruitingNCT06814990Not applicable1 country
- Association of Lipoprotein(a) With Postoperative Atrial FibrillationNot yet recruitingNCT07737444